Cambridge Investment Research Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,130
| Closed | -$22K | – | 3568 |
|
|
2024
Q3 | $22K | Hold |
13,130
| – | – | ﹤0.01% | 3362 |
|
|
2024
Q2 | $18K | Buy |
13,130
+1,196
| +10% | +$1.64K | ﹤0.01% | 3269 |
|
|
2024
Q1 | $45K | Sell |
11,934
-90,867
| -88% | -$343K | ﹤0.01% | 3218 |
|
|
2023
Q4 | $1.01M | Buy |
+102,801
| New | +$1.01M | ﹤0.01% | 1653 |
|
|
2021
Q4 | – | Sell |
-7,997
| Closed | -$204K | – | 3248 |
|
|
2021
Q3 | $204K | Sell |
7,997
-73,668
| -90% | -$1.88M | ﹤0.01% | 2801 |
|
|
2021
Q2 | $2.86M | Buy |
81,665
+71,526
| +705% | +$2.5M | 0.01% | 926 |
|
|
2021
Q1 | $338K | Buy |
+10,139
| New | +$338K | ﹤0.01% | 2197 |
|
|
2020
Q4 | – | Sell |
-17,141
| Closed | -$169K | – | 2764 |
|
|
2020
Q3 | $169K | Buy |
+17,141
| New | +$169K | ﹤0.01% | 2289 |
|